Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients
- 20 April 2013
- journal article
- liver cancer
- Published by Wiley in Liver International
- Vol. 33 (10) , 1594-1600
Abstract
Background The role of clinically significant portal hypertension on the prognosis of cirrhotic patients undergoing hepatic resection for hepatocellular carcinoma (HCC) is debated. Aims In this study, our aim was to assess the role of clinically significant portal hypertension after hepatic resection for HCC in patients with cirrhosis. Methods We assessed the prognostic role of the presence of clinically significant portal hypertension (oesophageal/gastric varices/portal hypertensive gastropathy or a platelet count 9/L associated with splenomegaly) in 152 patients with compensated cirrhosis who underwent hepatic resection for HCC at the Italian Liver Cancer centres. Survival rates were assessed in the whole series, in the subgroup of Child‐Pugh score 5 patients with uninodular HCC ≤5 cm, and in Child‐Pugh score 5 patients with uninodular HCC ≤2 cm and normal bilirubin. Results Median survival was similar in patients with and without clinically significant portal hypertension (79 vs 77 months, P = 0.686). Child‐Pugh score 5 was the only variable significantly associated with survival by Cox multiple regression (P = 0.007). In Child‐Pugh score 5 patients with single HCC ≤5 cm or in those with single HCC ≤2 cm and normal bilirubin, there was no survival difference between patients with and without clinically significant portal hypertension (median survival: 94 vs 78 months, P = 0.121 and >100 vs 86 months, P = 0.742). Conclusions Presence of clinically significant portal hypertension has no influence on survival of patients with well‐compensated cirrhosis undergoing hepatic resection for HCC.Keywords
This publication has 36 references indexed in Scilit:
- What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection?Digestive and Liver Disease, 2012
- Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosisBritish Journal of Surgery, 2012
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference reportThe Lancet Oncology, 2012
- Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patientsWorld Journal of Gastroenterology, 2012
- Liver Transplantation for Hepatocellular Carcinoma: Lessons Learned and Future DirectionsClinics in Liver Disease, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- The changing pattern of epidemiology in hepatocellular carcinomaDigestive and Liver Disease, 2010
- Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan®) before curative resection of hepatocellular carcinoma: a pilot studyHepatology International, 2008
- Thrombocytopenia in liver diseaseCurrent Opinion in Hematology, 2008
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005